Medical Advocates
New and Noteworthy
 
 December 14, 2017

Featured Report
Clinical Management Update
Drug Update
Diagnostic/Monitoring Update
Marginalized Update
US Update
Global Update
Today's Video

Home Page


This web page is best viewed by using INTERNET EXPLORER
All Citations are abstracts UNLESS OTHERWISE NOTED
 
Today's Featured Report
 

HCV immune evasion and regulatory T cell activation: cause or consequence?
Li H, Li T, Crispe IN, Tu Z.
Cell Mol Immunol. 2017 Nov 27



Hepatics C Infection/Disease

 
Disease Management Update
  Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1.
BP, Morgan JR, Pho MT,  et sal
Open Forum Infect Dis. 2016 Dec 27;

 

Hepatics C Infection/Disease

 
Drug Update
  Single-Dose and Multiple-Dose Pharmacokinetics of Vaniprevir in Healthy Men.
Caro L, de Hoon J, Depré M, et al
Clin Transl Sci. 2017 Nov;10(6
 


Vaniprevir

 
Diagnostic/Monitoring Update
 

How Does Imaging of Congenital Zika Compare with Imaging of Other TORCH Infections?
Levine D, Jani JC, Castro-Aragon I, Cannie M.
Radiology. 2017 Dec;285(3):744-761.

 

 
 
Marginalized Update
  Contraceptive Use Among HIV-Infected Females with History of Injection Drug Use in St. Petersburg, Russia.
West BS, Cheng DM, Toussova O, et al
AIDS Behav. 2017 Nov

 

Women and HIV

 
US Update
 
Towards the Elimination of Hepatitis C in the United States.
Saab S, Le L, Saggi S, Sundaram V, Tong M.
Hepatology. 2017 Nov 27. 




Hepatics C Infection/Disease

 
Global Update
  Hepatitis C in Poland in 2015
Zakrzewska K, Szmulik K, Stępień M, Rosińska M.
Przegl Epidemiol. 2015;71(3):363-371
 

 

Hepatics C Infection/Disease


Today's Video

National Survey of Young Adults on HIV/AIDS 

 

 

 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
 

NEW AND NOTEWORTHY
The New and Noteworthy Web features a daily interdisciplinary focus on current journal, conference,
and video reports on clinical, political, ethical, spiritual, economic, and human rights
dimensions of life-threatening infectious diseases and violence, and the related challenges to
the marginalized affected by these diseases and behaviors.